Cargando…

The increasing threat of silver-resistance in clinical isolates from wounds and burns

PURPOSE: The widespread use of silver-containing compounds has led to emergence of silver-resistant bacteria. Few studies are available on the detectability of plasmid-mediated silver-resistance in developing countries. Therefore, we aimed to detect silver-resistance in isolates from wounds and burn...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosny, Alaa El-Dien MS, Rasmy, Salwa A, Aboul-Magd, Dina S, Kashef, Mona T, El-Bazza, Zeinab E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636436/
https://www.ncbi.nlm.nih.gov/pubmed/31372006
http://dx.doi.org/10.2147/IDR.S209881
_version_ 1783436061582557184
author Hosny, Alaa El-Dien MS
Rasmy, Salwa A
Aboul-Magd, Dina S
Kashef, Mona T
El-Bazza, Zeinab E
author_facet Hosny, Alaa El-Dien MS
Rasmy, Salwa A
Aboul-Magd, Dina S
Kashef, Mona T
El-Bazza, Zeinab E
author_sort Hosny, Alaa El-Dien MS
collection PubMed
description PURPOSE: The widespread use of silver-containing compounds has led to emergence of silver-resistant bacteria. Few studies are available on the detectability of plasmid-mediated silver-resistance in developing countries. Therefore, we aimed to detect silver-resistance in isolates from wounds and burns, and to genetically characterize plasmid-mediated silver-resistance genes (sil genes). METHODS: One hundred and fifty clinical isolates were obtained from burns and wounds. They were identified using the suitable Analytical Profile Index and MicroScan identification systems. Their antimicrobial susceptibility was tested by the disk diffusion and broth microdilution methods. Their silver nitrate (AgNO(3)) minimum inhibitory concentration (MIC) was determined using the broth macrodilution method. The presence of different sil genes on plasmids extracted from silver-resistant isolates and the replicon types of the extracted plasmids were investigated using polymerase chain reaction (PCR). The ability of these plasmids to impart silver-resistance was tested by transformation. RESULTS: All except two isolates were multidrug-resistant. Nineteen silver-resistant bacterial isolates (12.6%) were detected; with AgNO(3) MIC ≥512 µg/mL. They were identified as Klebsiella pneumoniae (n=7), Staphylococcus aureus (n=4), Escherichia coli (n=2), Enterobacter cloacae (n=2), Pseudomonas aeruginosa (n=2) and Acinetobacter baumannii (n=2). PCR revealed the presence of different sil genes on the extracted plasmids. Plasmid transformation resulted in the transfer of silver-resistance to the resulting transformants. The extracted plasmids had different replicon types. CONCLUSION: Plasmid-mediated silver-resistance was detected for the first time, in clinical P. aeruginosa, A. baumannii and S. aureus isolates; in addition to its detection in K. pneumoniae, E. coli and Enterobacter cloacae. Therefore, strict monitoring on the use of silver compounds in medical settings is required; with implementation of an approved standardized method for silver-resistance detection.
format Online
Article
Text
id pubmed-6636436
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66364362019-08-01 The increasing threat of silver-resistance in clinical isolates from wounds and burns Hosny, Alaa El-Dien MS Rasmy, Salwa A Aboul-Magd, Dina S Kashef, Mona T El-Bazza, Zeinab E Infect Drug Resist Original Research PURPOSE: The widespread use of silver-containing compounds has led to emergence of silver-resistant bacteria. Few studies are available on the detectability of plasmid-mediated silver-resistance in developing countries. Therefore, we aimed to detect silver-resistance in isolates from wounds and burns, and to genetically characterize plasmid-mediated silver-resistance genes (sil genes). METHODS: One hundred and fifty clinical isolates were obtained from burns and wounds. They were identified using the suitable Analytical Profile Index and MicroScan identification systems. Their antimicrobial susceptibility was tested by the disk diffusion and broth microdilution methods. Their silver nitrate (AgNO(3)) minimum inhibitory concentration (MIC) was determined using the broth macrodilution method. The presence of different sil genes on plasmids extracted from silver-resistant isolates and the replicon types of the extracted plasmids were investigated using polymerase chain reaction (PCR). The ability of these plasmids to impart silver-resistance was tested by transformation. RESULTS: All except two isolates were multidrug-resistant. Nineteen silver-resistant bacterial isolates (12.6%) were detected; with AgNO(3) MIC ≥512 µg/mL. They were identified as Klebsiella pneumoniae (n=7), Staphylococcus aureus (n=4), Escherichia coli (n=2), Enterobacter cloacae (n=2), Pseudomonas aeruginosa (n=2) and Acinetobacter baumannii (n=2). PCR revealed the presence of different sil genes on the extracted plasmids. Plasmid transformation resulted in the transfer of silver-resistance to the resulting transformants. The extracted plasmids had different replicon types. CONCLUSION: Plasmid-mediated silver-resistance was detected for the first time, in clinical P. aeruginosa, A. baumannii and S. aureus isolates; in addition to its detection in K. pneumoniae, E. coli and Enterobacter cloacae. Therefore, strict monitoring on the use of silver compounds in medical settings is required; with implementation of an approved standardized method for silver-resistance detection. Dove 2019-07-08 /pmc/articles/PMC6636436/ /pubmed/31372006 http://dx.doi.org/10.2147/IDR.S209881 Text en © 2019 Hosny et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hosny, Alaa El-Dien MS
Rasmy, Salwa A
Aboul-Magd, Dina S
Kashef, Mona T
El-Bazza, Zeinab E
The increasing threat of silver-resistance in clinical isolates from wounds and burns
title The increasing threat of silver-resistance in clinical isolates from wounds and burns
title_full The increasing threat of silver-resistance in clinical isolates from wounds and burns
title_fullStr The increasing threat of silver-resistance in clinical isolates from wounds and burns
title_full_unstemmed The increasing threat of silver-resistance in clinical isolates from wounds and burns
title_short The increasing threat of silver-resistance in clinical isolates from wounds and burns
title_sort increasing threat of silver-resistance in clinical isolates from wounds and burns
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636436/
https://www.ncbi.nlm.nih.gov/pubmed/31372006
http://dx.doi.org/10.2147/IDR.S209881
work_keys_str_mv AT hosnyalaaeldienms theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT rasmysalwaa theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT aboulmagddinas theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT kashefmonat theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT elbazzazeinabe theincreasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT hosnyalaaeldienms increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT rasmysalwaa increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT aboulmagddinas increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT kashefmonat increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns
AT elbazzazeinabe increasingthreatofsilverresistanceinclinicalisolatesfromwoundsandburns